Company · CIK 0001023024 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ANI PHARMACEUTICALS INC · ANIP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 4:20 pm EDT | Nikhil LalwaniPRESIDENT & CEO, Director | 5,400 | $71.00 | $383,400 | 339,089 | −1.57% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 14, 8:56 pm EDT | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | 500 | $70.79 | $35,395 | 73,924 | −0.67% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 8:57 pm EDT | Jeanne ThomaDirector | 1,000 | $71.53 | $71,530 | 26,762 | −3.60% | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Sep 1, 6:18 pm EDT | Stephen P. CareySVP & CFO | 2,850 | $72.80 | $207,480 | 171,843 | −1.63% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.